precision medicine

Research in Review

Out-of-Pocket Costs May Delay TKI Initiation in Patients With CML

10/10/2016

JCP Editors

The significant out-of-pocket costs cancer patients face before Medicare Insurance drug benefits kick in may delay initiation of tyrosine-kinase inhibitor (TKI) therapy for chronic myeloid leukemia (CML), according...

The...

10/10/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of October 2-8

10/06/2016

JCP Editors

In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, researchers found that which form of radiation therapy offers similar health-related quality of life outcomes in...

In the...

10/06/2016

Journal of Clinical Pathways

Department

Biomarker Tied to Immunotherapy Response in Melanoma

09/30/2016

JCP Editors

Researchers at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, have identified a potential biomarker in patients with stage IV melanoma being treated with the immunotherapy...

...

09/30/2016

Journal of Clinical Pathways

Department

Trial Shows Precision Medicine Improves Cancer Survival

09/28/2016

JCP Editors

Data from the Paris-based Molecular Screening for Cancer Treatment Optimization (MOSCATO) trial demonstrates that establishing molecular portraits improves survival for patients with advanced cancer by tailoring...

Data...

09/28/2016

Journal of Clinical Pathways

Research in Review

ALK Inhibitor Treatment Response Better Predicted With Combo Genetic Screening

09/26/2016

JCP Editors

Combining fluorescence in situ hybridization (FISH) analysis and immunohistochemistry (IHC) assays may help to identify rare anaplastic lymphoma kinase (ALK) mutations in patients with non-small cell lung...

...

09/26/2016

Journal of Clinical Pathways

Department

Integrating Precision Medicine Into Chronic Lymphocytic Leukemia Pathways

09/21/2016

JCP Editors

“It is time to rethink how we treat chronic lymphocytic leukemia (CLL),” said Chadi Nabhan, MD, MBA, FACP, Cardinal Health Specialty Solutions (Chicago, IL) during a session at the Clinical Pathways Congress, where...

“It is...

09/21/2016

Journal of Clinical Pathways

Department

The End of Clinical Pathways?

09/19/2016

JCP Editors

In a presentation at the inaugural Clinical Pathways Congress, Michael Kolodziej, MD, national medical director, Managed Care Strategy, Flatiron Health, argued that clinical pathways as we know them will cease to...

In a...

09/19/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of September 11-17

09/14/2016

JCP Editors

In a study analyzing oxygen levels within cancer tumors, researchers found that adding which of the following drugs to standard care could help to prevent the development of treatment resistance in patients with...

In a...

09/14/2016

Journal of Clinical Pathways

Research in Review

Gene Assay May Predict Treatment Response in Lung Cancer

09/09/2016

JCP Editors

In a new study, researchers identified 14 centromere and kinetochore (CEN/KT) genes regulating genome integrity that were consistently overexpressed in a variety of cancers. This allowed the researchers to create the...

In a...

09/09/2016

Journal of Clinical Pathways

Research in Review

Esophageal Cancer Actually 3 Distinct Diseases

09/09/2016

JCP Editors

A study published in Nature Genetics claims that esophageal cancer may in fact be 3 distinct diseases, which could pave the way for new methods of diagnosis and spur the development of targeted treatment...

A...

09/09/2016

Journal of Clinical Pathways